These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of exotoxins in bacterial pathogenicity. Arbuthnott JP J Appl Bacteriol; 1978 Jun; 44(3):329-45. PubMed ID: 97256 [No Abstract] [Full Text] [Related]
4. [Recent advances in the molecular mechanism of action of bacterial toxins, in particular of diphtheria, cholera, coli, botulinum and shigella toxins as well as tetanospasmin and the toxins of staphylococcus aureus]. Kolb E Z Gesamte Inn Med; 1984 Mar; 39(6):85-92. PubMed ID: 6375175 [TBL] [Abstract][Full Text] [Related]
5. Genetic detoxification of bacterial toxins. Pizza M; Fontana MR; Scarlato V; Rappuoli R Methods Mol Med; 2003; 87():133-52. PubMed ID: 12958454 [No Abstract] [Full Text] [Related]
7. Proposal to remove an E. coli host-vector system producing a hybrid toxin from BL4 containment. Recomb DNA Tech Bull; 1985 Dec; 8(4):195-6. PubMed ID: 3912847 [No Abstract] [Full Text] [Related]
8. [Susceptibility of mice to tetanus and botulinum toxins as related to body weight and sex]. Zworska J Med Dosw Mikrobiol; 1972; 24(4):299-306. PubMed ID: 4655752 [No Abstract] [Full Text] [Related]
11. [Development of new generation of vaccine against pertussis, cholera, botulism, tetanus, and diphtheria toxins]. Ivanov KK Mol Gen Mikrobiol Virusol; 1993; (2):3-9. PubMed ID: 8515748 [No Abstract] [Full Text] [Related]
12. Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins. Kitamura M; Igimi S; Furukawa K; Furukawa K Biochim Biophys Acta; 2005 Jun; 1741(1-2):1-3. PubMed ID: 15919183 [TBL] [Abstract][Full Text] [Related]
14. Request for permission to lower containment conditions for the cloning of the gene for Shiga-like toxin from E. coli. Recomb DNA Tech Bull; 1984 Jun; 7(2):80-3. PubMed ID: 6382451 [No Abstract] [Full Text] [Related]
15. Summary of the 27th United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases. Spriggs DR; Guerrant RL J Infect Dis; 1993 Jan; 167(1):1-6. PubMed ID: 8093361 [No Abstract] [Full Text] [Related]
16. Tables of Toxicity of Botulinum and Tetanus Neurotoxins. Rossetto O; Montecucco C Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31771110 [TBL] [Abstract][Full Text] [Related]
17. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218 [TBL] [Abstract][Full Text] [Related]
18. Request for permission to lower containment conditions for the cloning of the gene for Shiga-like toxin from E. coli. Recomb DNA Tech Bull; 1984 Mar; 7(1):34. PubMed ID: 6374770 [No Abstract] [Full Text] [Related]
19. Medical aspects of biologic toxins. Marks JD Anesthesiol Clin North Am; 2004 Sep; 22(3):509-32, vii. PubMed ID: 15325716 [TBL] [Abstract][Full Text] [Related]
20. Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Mourad FH; Nassar CF Gut; 2000 Sep; 47(3):382-6. PubMed ID: 10940276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]